Nov 4th, 2009 - Los Angeles Times
Related topics:
Reporting from Washington - In an attempt to reduce the deaths and serious health problems caused by misuse of medication, the Food and Drug Administration is trying to identify the most serious threats and find ways to avoid them.
About 1.5 million preventable "adverse drug events" occur in the United States every year, according to a 2007 study by the Institute of Medicine, part of the National Academy of Sciences. Aside from the toll on health, the errors cost an estimated $4 billion a year, the study found.
Related stories:
Nuvo Research's US Pennsaid Saga Ends Happily >NRI.T
Nov 5th, 2009 - Wall Street Journal
TORONTO (Dow Jones)--It's taken the better part of a decade, but Nuvo Research Inc. (NRI.T) has finally landed U.S. approval of its topical pain medicine, Pennsaid. Earlier Thursday, the Canadian biotech - formerly known as Dimethaid - said the U.S...
FDA Moves to Curb Accidental Overdoses
Nov 5th, 2009 - CBS News
The Food and Drug Administration is launching a program to try and prevent millions of accidental drug overdoses that occur each year due to medication errors, misuse and other problems. Under the plan announced Wednesday...
Consumer group finds elevated BPA levels in range of foods
Nov 2nd, 2009 - Los Angeles Times
Reporting from Washington - A consumer advocacy group's analysis of canned goods has found measurable levels of the chemical additive bisphenol A, or BPA, across a range of foods...
Consumer group finds BPA in canned foods
Nov 5th, 2009 - seattlepi
Recent tests of canned food by Consumer Reports, a consumer testing organization, found that most of the 19 brand-name foods it examined contained some bisphenol A or BPA...
FDA Initiative Targets Drug Prescription, Dosing Errors
Nov 4th, 2009 - Washington Post
The Food and Drug Administration wants to reduce the misuse of medications, saying that at least 50,000 hospitalizations a year could be prevented if physicians, pharmacists...
Related videos from YouTube:
3:55QUMAS: FDA's Progress with Risk-based Approach to Compliance
The video blog features QUMAS Compliance Advisor, Warren Perry, who has worked with a number of multi-national Life Sciences firms on regulatory compliance, submission lifecycle management and e-submissions initiatives. This video ...
5:21John Karanian of FDA's CDRH on Predicting the Safety of Drug-Device Combinations
Dr. John Karanian, Director of the cardiovascular therapeutics lab at FDA's Center for Devices and Radiological Health, offered an overview of how his team is working to determine predictive safety of drug-device combinations ...
4:19Quality by Design 2- FDA's OPS Director Helen Winkle on QbD Initiatives Within FDA
Helen Winkle, Director of FDA's CDER's Office of Pharmaceutical Science, discusses QbD efforts within three different divisions of FDA: Office of New Drug Quality, Office of Biotechnology Products and Office of Generic Drugs. Ms ...
1:12CNN Reports on Hemopurifier
®, a first-in-class medical device to treat infectious disease. The Hemopurifier® addresses the largest opportunity in infectious disease, the treatment of drug and vaccine resistant viruses. Regulatory and commercialization initiatives in the United States are focused on bioterror threats ...
